0001209191-22-001621.txt : 20220105
0001209191-22-001621.hdr.sgml : 20220105
20220105160041
ACCESSION NUMBER: 0001209191-22-001621
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gharib Samir M.
CENTRAL INDEX KEY: 0001533302
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39594
FILM NUMBER: 22511030
MAIL ADDRESS:
STREET 1: 2655 PINE STREET
STREET 2: #6
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001683553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812154263
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 294-1687
MAIL ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-31
0
0001683553
SPRUCE BIOSCIENCES, INC.
SPRB
0001533302
Gharib Samir M.
2001 JUNIPERO SERRA BOULEVARD, SUITE 640
DALY CITY
CA
94014
0
1
0
0
President & CFO
Common Stock
2021-12-31
5
J
0
E
2220
3.791
A
4632
D
Employee Stock Option (right to buy)
4.59
2022-01-03
4
A
0
70000
0.00
A
2032-01-02
Common Stock
70000
70000
D
Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The Reporting Person acquired the maximum shares allowable pursuant to Section 423 of the Internal Revenue Code.
1/48th of the shares vest on a monthly basis from January 3, 2022, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan).
/s/ Samir Gharib
2022-01-05